摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

顺式-2-((叔丁氧羰基)氨基)-3-(4-氨甲酰基-2,6-二甲苯基)丙烯酸甲酯 | 864825-84-3

中文名称
顺式-2-((叔丁氧羰基)氨基)-3-(4-氨甲酰基-2,6-二甲苯基)丙烯酸甲酯
中文别名
——
英文名称
(Z)-2-tert-Butoxycarbonylamino-3-(4-carbamoyl-2,6-dimethyl-phenyl)acrylic acid methyl ester
英文别名
2-Propenoic acid, 3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-2-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (2Z)-;methyl (Z)-3-(4-carbamoyl-2,6-dimethylphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]prop-2-enoate
顺式-2-((叔丁氧羰基)氨基)-3-(4-氨甲酰基-2,6-二甲苯基)丙烯酸甲酯化学式
CAS
864825-84-3
化学式
C18H24N2O5
mdl
——
分子量
348.399
InChiKey
JTRKHURHLHATAD-ZROIWOOFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    可溶于氯仿(轻微、加热)、DMSO(轻微)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    25
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    108
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 危险性防范说明:
    P261,P280,P301+P312,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

反应信息

点击查看最新优质反应信息

文献信息

  • Novel compounds as opioid receptor modulators
    申请人:Breslin J. Henry
    公开号:US20050203143A1
    公开(公告)日:2005-09-15
    The present invention is directed to novel opioid receptor modulators of Formula (I). The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
    本发明涉及式(I)的新型阿片受体调节剂。该发明进一步涉及制备这类化合物的方法、包含它们的药物组合物,以及它们在治疗可通过调节阿片受体得到改善或治疗的疾病中的用途。
  • [EN] NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS<br/>[FR] NOUVEAUX COMPOSES EN TANT QUE MODULATEURS DE RECEPTEURS D'OPIOIDES
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2005090315A1
    公开(公告)日:2005-09-29
    The present invention is directed to novel opioid receptor modulators of Formula: (I). The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
    本发明涉及公式(I)的新型阿片受体调节剂。本发明还涉及制备这种化合物的方法,含有它们的药物组合物以及它们在治疗可能通过调节阿片受体得到改善或治疗的疾病中的使用。
  • NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS
    申请人:Breslin J. Henry
    公开号:US20080096888A1
    公开(公告)日:2008-04-24
    The present invention is directed to novel opioid receptor modulators of Formula (I). The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
    本发明涉及式(I)的新型阿片受体调节剂。本发明还涉及制备这些化合物的方法、含有它们的药物组合物以及它们在治疗可能通过调节阿片受体改善或治疗的疾病中的应用。
  • PROCESS FOR THE PREPARATION OF OPIOD MODULATORS
    申请人:Cai Chaozhong
    公开号:US20100036132A1
    公开(公告)日:2010-02-11
    The present invention is directed to novel processes for the preparation of opioid modulators (agonists and antagonists) and intermediates in their synthesis. The opioid modulators are useful for the treatment and prevention of as pain and gastrointestinal disorders.
    本发明涉及制备阿片类调节剂(激动剂和拮抗剂)及其合成中间体的新型工艺。这些阿片类调节剂可用于治疗和预防疼痛和胃肠道疾病。
  • PROCESS FOR THE PREPARATION OF OPIOID MODULATORS
    申请人:Cai Chaozhong
    公开号:US20100152460A1
    公开(公告)日:2010-06-17
    The present invention is directed to novel processes for the preparation of opioid modulators (agonists and antagonists) and intermediates in their synthesis. The opioid modulators are useful for the treatment and prevention of as pain and gastrointestinal disorders.
    本发明涉及一种新型工艺,用于制备阿片类调节剂(激动剂和拮抗剂)及其合成中间体。这些阿片类调节剂可用于治疗和预防疼痛和胃肠障碍。
查看更多